In vivo glycan engineering at the cell-matrix interface to control stem cell fate
细胞-基质界面的体内聚糖工程控制干细胞命运
基本信息
- 批准号:8955575
- 负责人:
- 金额:$ 232.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-30 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAffinityBiologyCell surfaceCellsDevelopmentEngineeringGenetic TranscriptionGoalsGrowth FactorGrowth Factor InteractionIn SituLaboratoriesMedicineOutcomePlayPolysaccharidesProductionRegenerative MedicineSignal TransductionSolutionsStem cellsStructureSurfaceTechniquesTherapeuticTissue EngineeringTissuesTransplantationWorkcell typein vivointerestmorphogensnanoscalenovelpublic health relevancereceptorrepairedstem cell fatestem cell fate specificationstem cell technologystem cell therapytargeted delivery
项目摘要
DESCRIPTION (provided by applicant): Stem cells have the remarkable ability to develop into a range of functional cell types of the adult body that can be used to repair damaged or diseased tissues. Despite advances in achieving selective differentiation in the laboratory, controlling the fate of stem cells post-transplantation still remains an unsolved challenge and a significant obstacle to the use of stem cells as therapeutics. Stem cell specification during development is orchestrated by the concerted action of morphogens, such as growth factors, which initiate intracellular signaling cascades activating gene transcription. Glycans populating surfaces of stem cells play a key role in regulating the interactions of growth factors with their cognate receptors; however, their regulatory functions have been largely unexplored in the context of achieving selectivity in differentiation. The objective of the proposed projects is to create new techniques for manipulating glycan structures at the surface of stem cells to tune the association of endogenous growth factors at the cell-matrix interface in vivo. Two distinct approaches are proposed to achieve this goal. The first approach describes priming of the stem cell surface prior to transplantation with nanoscale glycomimetic materials with affinity for a growth factor of interest. Once the remodeled cells are delivered to a tissue, these materials will
promote the association of the endogenous growth factor and activate signaling and differentiation. The second approach outlines the targeted delivery of these materials to the surface of stem cells in vivo concomitant with the inhibition of glycan production in these cells. This in situ remodeling will allow us to temporarily override native glycan signals at a critical junction to achieve selective activation of growth factor signaling and a desired differentiation outcome. This work will provide a novel solution to a key problem in the field of regenerative medicine and will open new opportunities for exploration of the rich biology of glycans for applications in stem cell technologies, tissue engineering and biomedicine.
描述(由适用提供):干细胞具有出色的能力,可以发展成成人身体的一系列功能细胞类型,可用于修复受损或解剖的组织。尽管在实验室实现选择性分化方面取得了进步,但在移植后控制干细胞的命运仍然是未解决的挑战,也是使用干细胞作为治疗的重要障碍。发育过程中的干细胞规范由形态因子的一致作用(例如生长因子)策划,这些因子启动细胞内信号传导级联激活基因转录。干细胞表面的聚糖在确定生长因子与同源受体的相互作用方面起着关键作用。但是,它们的调节功能在差异化的选择性的背景下在很大程度上是出乎意料的。拟议项目的目的是创建用于操纵干细胞表面的聚糖结构的新技术,以调整体内细胞 - 矩阵界面上内源性生长因子的关联。提出了两种不同的方法来实现这一目标。第一种方法描述了在用纳米级糖基材料移植之前对干细胞表面的启动,具有对生长感兴趣的生长因子的亲和力。一旦将重塑的细胞输送到组织,这些材料将
促进内源生长因子的关联并激活信号传导和分化。第二种方法概述了这些材料的靶向递送到干细胞表面的体内与这些细胞中聚糖产生的抑制。这种原位重塑将使我们能够在关键连接处暂时覆盖天然聚糖信号,以实现生长因子信号传导和所需分化结果的选择性激活。这项工作将为再生医学领域的关键问题提供新的解决方案,并将为探索聚糖在干细胞技术,组织工程和生物医学中应用的丰富生物学开放新的机会。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glycocalyx Remodeling with Glycopolymer-Based Proteoglycan Mimetics.
使用基于糖聚合物的蛋白聚糖模拟物进行糖萼重塑。
- DOI:10.1007/978-1-4939-3130-9_17
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:Huang,MiaL;Smith,RaymondAA;Trieger,GregW;Godula,Kamil
- 通讯作者:Godula,Kamil
Biologically Derived Neoproteoglycans for Profiling Protein–Glycosaminoglycan Interactions
用于分析蛋白质与糖胺聚糖相互作用的生物衍生新蛋白聚糖
- DOI:10.1021/acschembio.2c00205
- 发表时间:2022
- 期刊:
- 影响因子:4
- 作者:Porell, Ryan N.;Follmar, Julianna L.;Purcell, Sean C.;Timm, Bryce;Laubach, Logan K.;Kozirovskiy, David;Thacker, Bryan E.;Glass, Charles A.;Gordts, Philip L.;Godula, Kamil
- 通讯作者:Godula, Kamil
Glycocalyx Scaffolding to Control Cell Surface Glycan Displays.
- DOI:10.1002/cpch.40
- 发表时间:2018-06
- 期刊:
- 影响因子:0
- 作者:Huang ML;Tota EM;Verespy S 3rd;Godula K
- 通讯作者:Godula K
Stem Cell Microarrays for Assessing Growth Factor Signaling in Engineered Glycan Microenvironments.
- DOI:10.1002/adhm.202101232
- 发表时间:2022-03
- 期刊:
- 影响因子:10
- 作者:Michalak AL;Trieger GW;Trieger KA;Godula K
- 通讯作者:Godula K
Following sugar patterns in search of galectin function.
遵循糖模式寻找半乳糖凝集素功能。
- DOI:10.1073/pnas.1801039115
- 发表时间:2018
- 期刊:
- 影响因子:11.1
- 作者:Godula,Kamil
- 通讯作者:Godula,Kamil
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kamil Godula其他文献
Kamil Godula的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kamil Godula', 18)}}的其他基金
Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
- 批准号:
10588085 - 财政年份:2023
- 资助金额:
$ 232.5万 - 项目类别:
Glycan engineering via exoplasmic Golgi shuttle of glycosylation building blocks and modulators
通过糖基化构件和调节剂的外质高尔基体穿梭进行聚糖工程
- 批准号:
9809104 - 财政年份:2019
- 资助金额:
$ 232.5万 - 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
- 批准号:
8719535 - 财政年份:2013
- 资助金额:
$ 232.5万 - 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
- 批准号:
8728007 - 财政年份:2013
- 资助金额:
$ 232.5万 - 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
- 批准号:
8916112 - 财政年份:2013
- 资助金额:
$ 232.5万 - 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
- 批准号:
8091489 - 财政年份:2011
- 资助金额:
$ 232.5万 - 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
- 批准号:
8286932 - 财政年份:2011
- 资助金额:
$ 232.5万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 232.5万 - 项目类别:
Investigating how bHLH circuits integrate signals for cell fate decisions
研究 bHLH 电路如何整合信号以决定细胞命运
- 批准号:
10722452 - 财政年份:2023
- 资助金额:
$ 232.5万 - 项目类别:
Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis
表观遗传分子减轻牙周炎表型的潜力
- 批准号:
10736171 - 财政年份:2023
- 资助金额:
$ 232.5万 - 项目类别: